Kathy Perez has a diverse work experience spanning over several companies. Kathy is currently working as the Head of Global Patient Advocacy and Policy at argenx, a position they have held since April 2019. Prior to that, they served as an Independent Consultant, where they worked as a Guest Blogger from November 2018 to January 2020.
Before their role as an Independent Consultant, Perez worked at Halozyme Therapeutics, Inc. from January 2016 to November 2018. Kathy held the position of Sr. Director Medical Affairs, Advocacy, Awareness and Engagement, where they were responsible for leading clinical trial awareness, developing academic collaborations, and managing medical education grants and sponsorships. Perez also worked as the Director of Oncology Professional Relations at Halozyme Therapeutics, Inc. for a short period from June 2015 to January 2016.
Prior to their time at Halozyme Therapeutics, Inc., Perez worked at Shionogi Inc. as the US Lead of Advocacy and Professional Relations from September 2014 to February 2015. Before this role, they served as a District Sales Manager from May 2013 to August 2014. At Shionogi Inc., Perez was involved in launching Osphena and focused on generating key opinion leaders and condition advocacy for postmenopausal women.
Perez began their career at Amgen in 2002, where they held various positions over a span of 11 years. Kathy was an Executive Director of Marketing and Alliance Development from October 2008 to April 2013, leading budget and strategic planning for the Prolia brand and developing partnerships with non-profit organizations. Prior to this, they worked as the Director of Compliance and Medical Education Department Head from August 2006 to November 2008, leading a compliance operation budget and participating in industry code development. Perez also served as the Director of Compliance, Nephrology, and Sr. Manager of Sales Planning and Operations and Sales Training at Amgen.
Before joining Amgen, Perez worked at Pharmacia & Upjohn as a District Sales Manager from December 1984 to October 2002.
Overall, Kathy Perez has a strong background in patient advocacy, policy development, medical affairs, and sales and marketing across the biopharmaceutical industry.
Kathy Perez earned their Bachelor of Arts (B.A.) degree in Speech Communication and Rhetoric from California State University, Northridge, from 1982 to 1984.
April, 2019 - present
January, 2020